Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 12/2018

17.09.2018 | Original Article – Cancer Research

MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1

verfasst von: Xin-Long Ma, Feng Shang, Wei Ni, Jin Zhu, Bin Luo, Yu-Qi Zhang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

MicroRNAs (miRs) play an important role in many cancers and can affect cancer cell behavior, including glioma. This study aims at investigating the effects of miR-338-5p on the senescence, migration, invasion, and apoptosis of glioma cells via MAPK-signaling pathway by binding to FOXD1.

Methods

Gene expression microarray analysis was performed to screen differentially expressed miRNAs associated with glioma. Glioma tissues and adjacent tissues were collected. siRNA, mimic, and inhibitor were introduced for investigating the tumor suppressor role of miR-338-5p in glioma. Proliferation, migration, invasion, senescence, cell-cycle distribution, and apoptosis after transfection were detected by MTT assay, scratch test, Transwell assay, β-galactosidase staining, and flow cytometry, respectively.

Results

FOXD1 was identified as the up-regulated gene in glioma based on microarray data of GSE65626. FOXD1 was the target gene of miR-338-5p. Glioma tissues had increased expression of FOXD1, MEK-2, ERK-1, DAF, PCNA, and Bcl-2, and decreased expression of miR-338-5p and Bax. In cell experiments, after transfected with overexpressed miR-338-5p, higher expression of miR-338-5p, Bax, CD133, ZEB1, SOX2, SNAI1, and MMP2, but lower expression of FOXD1, MEK-2, ERK-1, Bcl-2, DAF, and PCNA were found accompanied with weaker proliferation, migration and invasion as well as stemness abilities but stronger senescence and higher apoptosis rate.

Conclusion

We found that overexpression of miR-338-5p suppresses glioma cell proliferation, migration, and invasion and accelerates its senescence and apoptosis by decreasing FOXD1 expression via inhibition of activation of MAPK-signaling pathway.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Alexiou GA, Tsiouris S, Kyritsis AP, Voulgaris S, Argyropoulou MI, Fotopoulos AD (2009) Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 95:1–11PubMed Alexiou GA, Tsiouris S, Kyritsis AP, Voulgaris S, Argyropoulou MI, Fotopoulos AD (2009) Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 95:1–11PubMed
Zurück zum Zitat Ames H, Halushka MK, Rodriguez FJ (2017) miRNA regulation in gliomas: usual suspects in glial tumorigenesis and evolving clinical applications. J Neuropathol Exp Neurol 76:246–254PubMed Ames H, Halushka MK, Rodriguez FJ (2017) miRNA regulation in gliomas: usual suspects in glial tumorigenesis and evolving clinical applications. J Neuropathol Exp Neurol 76:246–254PubMed
Zurück zum Zitat Annabi B, Lachambre MP, Plouffe K, Sartelet H, Beliveau R (2009) Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol Carcinog 48:910–919PubMed Annabi B, Lachambre MP, Plouffe K, Sartelet H, Beliveau R (2009) Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol Carcinog 48:910–919PubMed
Zurück zum Zitat Besse A et al (2016) MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumour Biol J Int Soc Oncodev Biol Med 37:7719–7727 Besse A et al (2016) MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumour Biol J Int Soc Oncodev Biol Med 37:7719–7727
Zurück zum Zitat Chen W, Qi J, Bao G, Wang T, Du CW, Wang MD (2015) Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. Mol Med Rep 12:1515–1523PubMed Chen W, Qi J, Bao G, Wang T, Du CW, Wang MD (2015) Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. Mol Med Rep 12:1515–1523PubMed
Zurück zum Zitat Cheng P et al (2016) FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Res 76:7219–7230PubMedPubMedCentral Cheng P et al (2016) FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Res 76:7219–7230PubMedPubMedCentral
Zurück zum Zitat Cui H et al (2016) Methylation of the miR-126 gene associated with glioma progression. Fam Cancer 15:317–324PubMed Cui H et al (2016) Methylation of the miR-126 gene associated with glioma progression. Fam Cancer 15:317–324PubMed
Zurück zum Zitat Erlich RB et al (2007) STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 55:1690–1698PubMed Erlich RB et al (2007) STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 55:1690–1698PubMed
Zurück zum Zitat Figarella-Branger D, Labrousse F, Mohktari K, Societe franc aise de n, Reseau de neuro-oncologie p (2012) Guidelines for adult diffuse gliomas WHO grade II, III and IV: pathology and biology. Societe franc aise de neuropathologie. Reseau de neuro-oncologie pathologique. Annales de pathologie 32:318–327PubMed Figarella-Branger D, Labrousse F, Mohktari K, Societe franc aise de n, Reseau de neuro-oncologie p (2012) Guidelines for adult diffuse gliomas WHO grade II, III and IV: pathology and biology. Societe franc aise de neuropathologie. Reseau de neuro-oncologie pathologique. Annales de pathologie 32:318–327PubMed
Zurück zum Zitat Foreman PM, Friedman GK, Cassady KA, Markert JM (2017) Oncolytic virotherapy for the treatment of malignant glioma. Neurother J Am Soc Exp Neurother 14:333–344 Foreman PM, Friedman GK, Cassady KA, Markert JM (2017) Oncolytic virotherapy for the treatment of malignant glioma. Neurother J Am Soc Exp Neurother 14:333–344
Zurück zum Zitat Gao YF et al (2017) Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells. Oncol Rep 37:1196–1202PubMed Gao YF et al (2017) Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells. Oncol Rep 37:1196–1202PubMed
Zurück zum Zitat Hall PA et al (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294PubMed Hall PA et al (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294PubMed
Zurück zum Zitat Hart MG, Garside R, Rogers G, Stein K, Grant R (2013) Temozolomide for high grade glioma. Cochrane Database Syst Rev 4:CD007415 Hart MG, Garside R, Rogers G, Stein K, Grant R (2013) Temozolomide for high grade glioma. Cochrane Database Syst Rev 4:CD007415
Zurück zum Zitat Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251PubMed Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251PubMed
Zurück zum Zitat Hua FF et al (2017) MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway. Eur Rev Med Pharmacol Sci 21:5342–5352PubMed Hua FF et al (2017) MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway. Eur Rev Med Pharmacol Sci 21:5342–5352PubMed
Zurück zum Zitat Jia Z et al (2018) Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma. Oncol Lett 15:8669–8680PubMedPubMedCentral Jia Z et al (2018) Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma. Oncol Lett 15:8669–8680PubMedPubMedCentral
Zurück zum Zitat Jiang B, Chaichana K, Veeravagu A, Chang SD, Black KL, Patil CG (2017) Biopsy versus resection for the management of low-grade gliomas. Cochrane Database Syst Rev 4:CD009319PubMed Jiang B, Chaichana K, Veeravagu A, Chang SD, Black KL, Patil CG (2017) Biopsy versus resection for the management of low-grade gliomas. Cochrane Database Syst Rev 4:CD009319PubMed
Zurück zum Zitat Karolak MJ, Guay JA, Oxburgh L (2018) Inactivation of Map3k7 in Foxd1-expressing cells results in loss of mesangial PDGFRbeta and juvenile kidney scarring. Am J Physiol Ren Physiol 315(2):F336–F344 Karolak MJ, Guay JA, Oxburgh L (2018) Inactivation of Map3k7 in Foxd1-expressing cells results in loss of mesangial PDGFRbeta and juvenile kidney scarring. Am J Physiol Ren Physiol 315(2):F336–F344
Zurück zum Zitat Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta 1802:396–405PubMed Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta 1802:396–405PubMed
Zurück zum Zitat Koga M et al (2014) Foxd1 is a mediator and indicator of the cell reprogramming process. Nat Commun 5:3197PubMed Koga M et al (2014) Foxd1 is a mediator and indicator of the cell reprogramming process. Nat Commun 5:3197PubMed
Zurück zum Zitat Lei D, Zhang F, Yao D, Xiong N, Jiang X, Zhao H (2017) MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomed Pharmacother (Biomedecine pharmacotherapie) 89:957–965 Lei D, Zhang F, Yao D, Xiong N, Jiang X, Zhao H (2017) MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomed Pharmacother (Biomedecine pharmacotherapie) 89:957–965
Zurück zum Zitat Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20 Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20
Zurück zum Zitat Li J, Jiang Z, Han F, Liu S, Yuan X, Tong J (2016) FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients. Oncotarget 7:25585–25592PubMedPubMedCentral Li J, Jiang Z, Han F, Liu S, Yuan X, Tong J (2016) FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients. Oncotarget 7:25585–25592PubMedPubMedCentral
Zurück zum Zitat Liang Z et al (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79:817–824PubMed Liang Z et al (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79:817–824PubMed
Zurück zum Zitat Lin F et al (2001) Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104:215–225PubMedPubMedCentral Lin F et al (2001) Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104:215–225PubMedPubMedCentral
Zurück zum Zitat Liu WT, Huang CY, Lu IC, Gean PW (2013) Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death. Neurooncology 15:1127–1141 Liu WT, Huang CY, Lu IC, Gean PW (2013) Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death. Neurooncology 15:1127–1141
Zurück zum Zitat Liu DZ, Zhao H, Zou QG, Ma QJ (2017) MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma. Cancer Biomark Sect A Dis Mark 20:289–297 Liu DZ, Zhao H, Zou QG, Ma QJ (2017) MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma. Cancer Biomark Sect A Dis Mark 20:289–297
Zurück zum Zitat Mamelak AN, Jacoby DB (2007) Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4:175–186PubMed Mamelak AN, Jacoby DB (2007) Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4:175–186PubMed
Zurück zum Zitat Metcalfe SE, Grant R (2001) Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev 3:CD002034 Metcalfe SE, Grant R (2001) Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev 3:CD002034
Zurück zum Zitat Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, Louis DN, Nutt CL (2006) Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol 65:1181–1188PubMed Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, Louis DN, Nutt CL (2006) Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol 65:1181–1188PubMed
Zurück zum Zitat Nakayama S et al (2015) FOXD1 expression is associated with poor prognosis in non-small cell lung cancer. Anticancer Res 35:261–268PubMed Nakayama S et al (2015) FOXD1 expression is associated with poor prognosis in non-small cell lung cancer. Anticancer Res 35:261–268PubMed
Zurück zum Zitat Nohata N, Goto Y, Gutkind JS (2017) Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. J Hum Genet 62:87–96PubMed Nohata N, Goto Y, Gutkind JS (2017) Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. J Hum Genet 62:87–96PubMed
Zurück zum Zitat Peng Y, Liu YM, Li LC, Wang LL, Wu XL (2014) MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PloS One 9:e94422PubMedPubMedCentral Peng Y, Liu YM, Li LC, Wang LL, Wu XL (2014) MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PloS One 9:e94422PubMedPubMedCentral
Zurück zum Zitat Reinhardt A et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica 136(2):273–291PubMed Reinhardt A et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica 136(2):273–291PubMed
Zurück zum Zitat Reuss D, von Deimling A (2009) Hereditary tumor syndromes and gliomas. Recent results in cancer research. Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 171:83–102PubMed Reuss D, von Deimling A (2009) Hereditary tumor syndromes and gliomas. Recent results in cancer research. Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 171:83–102PubMed
Zurück zum Zitat Song WS et al (2016) Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. J Chin Med Assoc 79:538–545PubMed Song WS et al (2016) Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. J Chin Med Assoc 79:538–545PubMed
Zurück zum Zitat Tan PG, Li ZQ, Cai WQ, Lu JP, Xie FS, Weng Y (2003) Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance. Aizheng Chin J Cancer (Ai zheng) 22:1077–1080 Tan PG, Li ZQ, Cai WQ, Lu JP, Xie FS, Weng Y (2003) Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance. Aizheng Chin J Cancer (Ai zheng) 22:1077–1080
Zurück zum Zitat Tanboon J, Williams EA, Louis DN (2016) The diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas. J Neuropathol Exp Neurol 75:4–18PubMed Tanboon J, Williams EA, Louis DN (2016) The diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas. J Neuropathol Exp Neurol 75:4–18PubMed
Zurück zum Zitat Toomey CB, Cauvi DM, Pollard KM (2014) The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease. Autoimmune Dis 2014:452853PubMedPubMedCentral Toomey CB, Cauvi DM, Pollard KM (2014) The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease. Autoimmune Dis 2014:452853PubMedPubMedCentral
Zurück zum Zitat Wang S, Lu S, Geng S, Ma S, Liang Z, Jiao B (2013) Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. Med Oncol 30:373PubMed Wang S, Lu S, Geng S, Ma S, Liang Z, Jiao B (2013) Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. Med Oncol 30:373PubMed
Zurück zum Zitat Wang F et al (2015a) Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells. Am J Transl Res 7:607–615PubMedPubMedCentral Wang F et al (2015a) Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells. Am J Transl Res 7:607–615PubMedPubMedCentral
Zurück zum Zitat Wang G, Sun Y, He Y, Ji C, Hu B, Sun Y (2015b) MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Int J Clin Exp Pathol 8:337–344PubMedPubMedCentral Wang G, Sun Y, He Y, Ji C, Hu B, Sun Y (2015b) MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Int J Clin Exp Pathol 8:337–344PubMedPubMedCentral
Zurück zum Zitat Wang SS et al (2016) CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation. Oncotarget 7:29051–29062PubMedPubMedCentral Wang SS et al (2016) CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation. Oncotarget 7:29051–29062PubMedPubMedCentral
Zurück zum Zitat Wang R et al (2018) Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma. OncoTargets Ther 11:1183–1192 Wang R et al (2018) Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma. OncoTargets Ther 11:1183–1192
Zurück zum Zitat Weller M et al (1997) Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol Res 19:459–470PubMed Weller M et al (1997) Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol Res 19:459–470PubMed
Zurück zum Zitat Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989–992PubMed Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989–992PubMed
Zurück zum Zitat Zhang ZZ, Shields LB, Sun DA, Zhang YP, Hunt MA, Shields CB (2015) The art of intraoperative glioma identification. Front Oncol 5:175PubMedPubMedCentral Zhang ZZ, Shields LB, Sun DA, Zhang YP, Hunt MA, Shields CB (2015) The art of intraoperative glioma identification. Front Oncol 5:175PubMedPubMedCentral
Zurück zum Zitat Zhao YF et al (2015) FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. Biochem Biophys Res Commun 456:232–237PubMed Zhao YF et al (2015) FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. Biochem Biophys Res Commun 456:232–237PubMed
Zurück zum Zitat Zhao Y, Chen J, Wei W, Qi X, Li C, Ren J (2018) The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma. Signal Transduct Target Ther 3:3PubMedPubMedCentral Zhao Y, Chen J, Wei W, Qi X, Li C, Ren J (2018) The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma. Signal Transduct Target Ther 3:3PubMedPubMedCentral
Zurück zum Zitat Zolota V et al (2014) Mitogen-activated protein kinases in gliomas and correlation with patients’ prognosis. Acta Neurol Scand 129:226–233 Zolota V et al (2014) Mitogen-activated protein kinases in gliomas and correlation with patients’ prognosis. Acta Neurol Scand 129:226–233
Metadaten
Titel
MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1
verfasst von
Xin-Long Ma
Feng Shang
Wei Ni
Jin Zhu
Bin Luo
Yu-Qi Zhang
Publikationsdatum
17.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 12/2018
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-018-2745-y

Weitere Artikel der Ausgabe 12/2018

Journal of Cancer Research and Clinical Oncology 12/2018 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.